Pacific Biosciences is trading 5.26% up now at $1.60, extending its recent rebound after an 18.75% gain on August 25, with sector momentum driving broad gains in biotechnology stocks and the XBI ETF.
- No new company-specific announcement dated August 26 was identified.
- The latest investor updates remain the August 5 earnings release, CEO transition, restructuring, and Vega product updates.